The possible role of genetic variants in autoimmune-related genes in the development of endometriosis

Human Immunology

Volumn 73, Issue 3, 2012, Pages 306-315

  Bianco, Bianca ^a   André, Gustavo M ^a   Vilarino, Fábia L ^a   Peluso, Carla ^a   Mafra, Fernanda Abani ^a   Christofolini, Denise M ^a   Barbosa, Caio P ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Autoimmunity; Endometriosis; Infertility; Polymorphism

Indexed keywords

ANGIOGENIC FACTOR; ANTIBODY; ANTIENDOMETRIAL ANTIBODY; ANTINUCLEAR ANTIBODY; CYCLOOXYGENASE 2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL CELL GROWTH FACTOR; FC RECEPTOR; FC RECEPTOR IIB; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE ACTIVATING FACTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RANTES; STAT4 PROTEIN; T LYMPHOCYTE RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLERGY; ASTHMA; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COMORBIDITY; CYTOKINE RELEASE; DISEASE COURSE; ECZEMA; ENDOMETRIOSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMORAL IMMUNITY; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MACROPHAGE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PATHOGENESIS; PERITONEAL FLUID; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; VAGINA SECRETION; WESTERN BLOTTING;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CYTOKINES; ENDOMETRIOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 84857115749     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.009     Document Type: Review

References (135)

1. Giudice L.C. Endometriosis. Lancet 2004, 364:1789-1799. Endometriosis KLC.
2. Barbosa C.P., Souza A.M., Bianco B., Christofolini D., Bach F.A., Lima G.R. Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values. Sao Paulo Med J 2009, 127:342-345.
3. Barbosa C.P., de Souza A.M., Bianco B., Christofolini D.M., Mafra F.A., de Lima G.R. OC-125 immunostaining in endometriotic lesion samples. Arch Gynecol Obstet 2010, 281:43-47.
4. Gao L., Li K., Li F., Li H., Liu L., Wang L., et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010, 57:51-56.
5. Bianco B., Christofolini D.M., Mafra F.A., Brandes A., Zulli K., Barbosa C.P. +1730 G/A polymorphism of the estrogen receptor beta gene (ERbeta) may be an important genetic factor predisposing to endometriosis. Acta Obstet Gynecol Scand 2009, 88:1397-1401.
6. Gomes F.M., Bianco B., Teles J.S., Christofolini D.M., de Souza A.M., et al. PTPN22 C1858T polymorphism in women with endometriosis. Am J Reprod Immunol 2010, 63:227-232.
7. Vilarino F.L., Bianco B., Lerner T.G., Teles J.S., Mafra F.A., Christofolini D.M., et al. Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Hum Immunol 2011, 72:359-363.
8. Levander G. Uber die pathologenese bei Endometriose. Arch Klin Chirg 1941, 202:497-515.
9. Meyer R. Ueber den Stand der Frage der adenomyositis und adenomyome in algemeinen und insbesondere über adenomyositis serosoepithelialis und adenomyometritis sarcomatosa. Zentralbl Gynäkol 1919, 43:745-750.
10. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 14:422-428.
11. Matarese G., De Placido G., Nikas Y., Alviggi C. Pathogenesis of endometriosis: Natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003, 9:223-228.
12. Osteen K.G., Bruner-Tran K.L., Eisenberg E. Reduced progesterone action during endometrial maturation: A potential risk factor for the development of endometriosis. Fertil Steril 2005, 83:529-537.
13. McLeod B.S., Retzloff M.G. Epidemiology of endometriosis: An assessment of risk factors. Clin Obstet Gynecol 2010, 53:389-396.
14. Bruner-Tran K.L., Ding T., Osteen K.G. Dioxin and endometrial progesterone resistance. Semin Reprod Med 2010, 28:59-68.
15. Geva E., Amit A., Lerner-Geva L., Lessing J.B. Autoimmunity and reproduction. Fertil Steril 1997, 67:599-611.
16. Szekeres-Bartho J., Barakonyi A., Miko E., Polgar B., Palcovics T. The role of c/d T cells in the feto-maternal relationship. Semin Immunol 2001, 13:229-233.
17. Tremellen K.P., Valbuena D., Landeras J., Ballesteros A., Martinez J., Mendoza S., et al. The effect of intercourse on pregnancy rates during assisted human reproduction. Hum Reprod 2000, 15:2653-2658.
18. Haller K., Salumets A., Grigorova M., Talja I., Salur L., Béné M.C., et al. Putative predictors of antibodies against follicle-stimulating hormone in female infertility: A study based on in vitro fertilization patients. Am J Reprod Immunol 2007, 57:193-200.
19. Anaya J.M., Gómez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13:185-195.
20. Nothnick W.B. Treating endometriosis as an autoimmune disease. Fertil Steril 2001, 76:223-231.
21. Nussbaum R.L., Mclness R.R., Willard H.F. Thompson & Thompson Genetics in Medicine 2008, Elsevier, Phildelphia. 7 Ed.
22. Seery J.P. Endometriosis associated with defective handling of apoptotic cells in the female genital tract is a major cause of autoimmune disease in women. Med Hypotheses 2006, 66:945-949.
23. Sinaii N., Cleary S.D., Ballweg M.L., Nieman L.K., Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: A survey analysis. Hum Reprod 2002, 17:2715-2724.
24. Barrier B.F. Immunology of endometriosis. Clin Obstet Gynecol 2010, 53:397-402.
25. Nielsen N.M., Jørgensen K.T., Pedersen B.V., Rostgaard K., Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011, 26:1555-1559.
26. Galli S.J., Nakae S. Mast cells to the defense. Nat Immunol 2003, 4:1160-1162.
27. Montalto M., Santoro L., D'Onofrio F., Gallo A., Campo S., Campo V., et al. Endometriosis, need for a multidisciplinary clinical setting: The internist's point of view. Intern. Emerg Med 2010, 5:463-467.
28. Montgomery G.W., Nyholt D.R., Zhao Z.Z., Treloar S.A., Painter J.N., Missmer S.A., et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008, 14:447-457.
29. Badawy S.Z.A., Cuenca V., Freliech H., Stefanu C. Endometrial antibodies in serum and peritoneal fluid of infertile patients with and without endometriosis. Fertil Steril 1990, 53:930-932.
30. Randall G.W., Gantt P.A., Poe-Zeigler R.L., et al. Serum antiendometrial antibodies and diagnosis of endometriosis. Am J Reprod Immunol 2007, 58:374-382.
31. Wild R.A., Shivers C.A. Antiendometrial antibodies in patients with endometriosis. Am J Reprod Immunol Microbiol 1985, 8:84-86.
32. Fernandéz-Shaw S., Kennedy S.H., Hicks B.R., Edmonds K., Starkey P.M., Barlow D.H. Anti-endometrial antibodies in women measured by an enzyme-linked immunosorbent assay. Hum Reprod 1996, 11:1180-1184.
33. Fernández-Shaw S., Hicks B.R., Yudkin P.L., Kennedy S., Barlow D.H., Starkey P.M. Anti-endometrial and anti-endothelial auto-antibodies in women with endometriosis. Hum Reprod 1993, 8:310-315.
34. Gajbhiye R., Suryawanshi A., Khan S., Meherji P., Warty N., Raut V., et al. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online 2008, 16:817-824.
35. Mathur S., Garza D.E., Smith L.F. Endometrial autoantigens eliciting immunoglobulin (Ig)G, IgA, and IgM responses in endometriosis. Fertil Steril 1990, 54:56-63.
36. Oosterlynck D.J., Meuleman C., Waer M., Vandeputte M., Koninckx P.R. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992, 58:290-295.
37. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., Kola I. Decreased natural killer cell activity in endometriosis patients: Relationship to disease pathogenesis. Fertil Steril 1994, 62:1086-1088.
38. Bartosik D., Jacobs S.L., Kelly L.J. Endometrial tissue in peritoneal fluid. Fertil Steril 1986, 46:796-800.
39. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., Caudle M.R. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995, 34:381-385.
40. Haney A.F., Muscato J.J., Weinberg J.B. Peritoneal fluid cell populations in infertility patients. Fertil Steril 1981, 35:696-698.
41. Koninckx P.R., Kennedy S.H., Barlow D.H. Endometriotic disease: The role of peritoneal fluid. Hum Reprod Update 1998, 4:741-751.
42. Richter O.N., Dorn C., Rösing B., Flaskamp C., Ulrich U. Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis. Arch Gynecol Obstet 2005, 271:143-147.
43. Gazvani R., Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002, 123:217-226.
44. Milewski L., Dziunycz P., Barcz E., Radomski D., Roszkowski P.I., Korczak-Kowalska G., et al. Increased levels of human neutrophil peptides 1, 2, and 3 in peritoneal fluid of patients with endometriosis: Association with neutrophils, T cells and IL-8. J Reprod Immunol 2011, 91:64-70.
45. Hirata T., Osuga Y., Hamasaki K., Yoshino O., Ito M., Hasegawa A., et al. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 2008, 149:1260-1267.
46. Zhang X., Xu H., Lin J., Qian Y., Deng L. Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. Br J Obstet Gynaecol 2005, 112:1153-1155.
47. Hirata T., Osuga Y., Takamura M., Saito A., Hasegawa A., et al. Interleukin-17F increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis. Fertil Steril 2011, 96:113-117.
48. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2004, 25:581-611.
49. Cosín R., Gilabert-Estellés J., Ramón L.A., Gómez-Lechón M.J., Gilabert J., Chirivella M., et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod 2010, 25:398-405.
50. Machado D.E., Berardo P.T., Palmero C.Y., Nasciutti L.E. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res 2010, 19:29-34.
51. Donnez J., Smoes P., Gillerot S., Casanas-Roux F., Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998, 13:1686-1690.
52. Tan X.J., Lang J.H., Liu D.Y., Shen K., Leng J.H., Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002, 78:148-153.
53. The Molecular Pathology of Autoimmune Diseases 2002, 127-141. Taylor & Francis, New York. (ed 2). T. Mustelin, A. Altman, A. Theofilopoulos, C.A. Bona (Eds.).
54. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
55. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
56. Ban Y., Tozaki T., Tobe T., Ban Y., Jacobson E.M., Concepcion E.S., et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007, 28:201-207.
57. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
58. André G.M., Barbosa C.P., Teles J.S., Vilarino F.L., Christofolini D.M., Bianco B. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril 2011, 95:2223-2227.
59. + and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: Implications for human reproduction. J Immunol 2007, 178:2572-2578.
60. + and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 2010, 8:116.
61. Polanczyk M.J., Hopke C., Vandenbark A.A., Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol 2007, 19:337-343.
62. Berbic M., Fraser I.S. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011, 88:149-155.
63. Tai P., Wang J., Jin H., Song X., Yan J., Kang Y., et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008, 214:456-464.
64. Bottini N., Bottini E., Gloria-Bottini F., Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: In search of biochemical mechanisms. Arch Immunol Ther Exp 2002, 50:95-104.
65. Vang T., Miletic A.V., Bottini N., Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007, 40:453-461.
66. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
67. Ammendola M., Bottini N., Pietropolli A., Saccucci P., Gloria-Bottini F. Association between PTPN22 and endometriosis. Fertil Steril 2008, 89:993-994.
68. Płoski R., Dziunycz P., Kostrzewa G., Roszkowski P.I., Barcz E., Zabek J., et al. PTPN22/LYP 1858C > T gene polymorphism and susceptibility to endometriosis in a Polish population. J Reprod Immunol 2009, 79:196-200.
69. Chistiakov D.A. Is CAP. 3 a new general autoimmunity gene?. Hum Immunol 2007, 68:375-383.
70. Teles J.S., Bianco B., Vilarino F.L., André G.M., Christofolini D.M., Barbosa C.P. Association of FCRL3 C-169T promoter single-nucleotide polymorphism with idiopathic infertility and infertility-related endometriosis. J Reprod Immunol 2011, 89:212-215.
71. Bianco B., Teles J.S., Lerner T.G., Vilarino F.L., Christofolini D.M., Barbosa C.P. Association of FCRL3 -169T/C polymorphism with endometriosis and identification of a protective haplotype against the development of the disease in Brazilian population. Hum Immunol 2011, 72:774-778.
72. Owen C.J., Kelly H., Eden J.A., Merriman M.E., Pearce S.H., Merriman T.R. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007, 92:1106-1111.
73. González-Ramos R., Van Langendonckt A., Defrère S., Lousse J.C., Colette S., Devoto L., et al. Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis. Fertil Steril 2010, 94:1985-1994.
74. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580.
75. Jiang Y., Hirose S., Abe M., Sanokawa-Akakura R., Ohtsuji M., Mi X., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000, 51:429.
76. Jiang Y., Hirose S., Sanokawa-Akakura R., Abe M., Mi X., Li N., et al. Genetically determined aberrant down-regulation of FcRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 1999, 11:1685.
77. Nakamura A., Yuasa T., Ujike A., Ono M., Nukiwa T., Ravetch J.V., et al. Fc receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000, 191:899.
78. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47.
79. Niederer H.A., Willcocks L.C., Rayner T.F., Yang W., Lau Y.L., Williams T.N., et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010, 19:3282-3294.
80. Tew J.G., Wu J., Fakher M., Szakal A.K., Qin D. Follicular dendritic cells: Beyond the necessity of T-cell help. Trends Immunol 2001, 22:361.
81. Haberman A.M., Shlomchik M.J. Reassessing the function of immune-complex retention by follicular dendritic cells. Nat Rev Immunol 2003, 3:757.
82. Kosco-Vilbois M.H. Are follicular dendritic cells really good for nothing?. Nat Rev Immunol 2003, 3:764.
83. Korman B.D., Kastner D.L., Gregersen P.K., Remmers E.F. STAT4: Genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 2008, 8:398-403.
84. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000, 25:496-502.
85. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
86. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
87. Barton A., Thomson W., Ke X., Eyre S., Hinks A., Bowes J., et al. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 2008, 17:2274-2279.
88. Gough S.C., Walker L.S., Sansom D.M. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005, 204:102-115.
89. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
90. Viganò P., Lattuada D., Mangioni S., Ermellino L., Vignali M., Caporizzo E., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006, 36:415-424.
91. Lerner T.G., Bianco B., Teles J.S., Vilarino F.L., Christofolini D.M., Barbosa C.P. Analysis of CTLA4 +49A/G variant in infertile Brazilian women with and without endometriosis. Int J Immunogenet 2011, 38:259-262.
92. Ponce C., Torres M., Galleguillos C., Sovino H., Boric M.A., Fuentes A., et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction 2009, 137:727-737.
93. Karban A.S., Okazaki T., Panhuysen C.I., Gallegos T., Potter J.J., Bailey-Wilson J.E., et al. Functional annotation of a novel NFκB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13:35-45.
94. Rueda B., Núñez C., López-Nevot M.A., Paz Ruiz M., Urcelay E., De la Concha E.G., et al. Functional polymorphism of the NFκB1 gene promoter is not relevant in predisposition to celiac disease. Scand J Gastroenterol 2006, 41:420-423.
95. Zhou B., Rao L., Peng Y., Wang Y., Qie M., Zhang Z., et al. A functional promoter polymorphism in NFκB1 increases susceptibility to endometriosis. DNA Cell Biol 2010, 29:235-239.
96. Weenink S.M., Gautam A.M. Antigen presentation by MHC class II molecules. Immunol Cell Biol 1997, 75:69-81.
97. Kumánovics A., Takada T., Lindahl K.F. Genomic organization of the mammalian MHC. Annu Rev Immunol 2003, 21:629-657.
98. Kong Y.C., Flynn J.C., Banga J.P., David C.S. Application of HLA class II transgenic mice to study autoimmune regulation. Thyroid 2007, 17:995-1003.
99. Wang X., Liu C., Lin Q., Fang X., Lin L., Mei Q. Study on polymorphism of human leukocyte antigen-DRB1 allele in patients with endometriosis. Zhonghua Fu Chan Ke Za Zhi 2002, 37:346-348.
100. Sundqvist J., Falconer H., Seddighzadeh M., Vodolazkaia A., Fassbender A., Kyama C., et al. Endometriosis and autoimmune disease: Association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil Steril 2011, 95:437-440.
101. Whang D.H., Kim S.H., Choi Y.M., Park M.H., Noh J.H., Kim Y.B. No association between HLA-DRB1 alleles and susceptibility to advanced stage endometriosis in a Korean population. Hum Reprod 2006, 21:129-133.
102. Coornaert B., Carpentier I., Beyaert R. A20: Central gatekeeper in inflammation and immunity. J Biol Chem 2009, 284:8217-8221.
103. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000, 289:2350-2354.
104. Compagno M., Lim W.K., Grunn A., Nandula S.V., Brahmachary M., Shen Q., Bertoni F., et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459:717-721.
105. Lodolce J.P., Kolodziej L.E., Rhee L., Kariuki S.N., Franek B.S., McGreal N.M., et al. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol 2010, 184:7001-7009.
106. Dawidowicz K., Allanore Y., Guedj M., Pierlot C., Bombardieri S., Balsa A., et al. The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis 2011, 70:117-121.
107. Sigurdsson S., Nordmark G., Göring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76:528-537.
108. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006, 38:550-555.
109. Han S.W., Lee W.K., Kwon K.T., Lee B.K., Nam E.J., Kim G.W. Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: A metaanalysis. J Rheumatol 2009, 36:693-697.
110. Dideberg V., Kristjansdottir G., Milani L., Libioulle C., Sigurdsson S., Louis E., et al. An insertion-deletion polymorphismin the interferon regulatory factor 5 (IRF5) gene confers risk of infl ammatory bowel diseases. Hum Mol Genet 2007, 16:3008-3016.
111. Kristjansdottir G., Sandling J.K., Bonetti A., Roos I.M., Milani L., Wang C., et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008, 45:362-369.
112. Nordmark G., Kristjansdottir G., Theander E., Eriksson P., Brun J.G., Wang C., et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 2009, 10:68-76.
113. Ely K.R., Li C. Structurally adaptive hot spots at a protein interaction interface on TRAF3. J Mol Recognit 2002, 15:286-290.
114. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
115. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996, 14:591-617.
116. Whitfield G.K., Hsieh J.C., Jurutka P.W., Selznick S.H., Haussler C.A., MacDonald P.N., et al. Genomic actions of 1,25-dihydroxyvitamin D3. J Nutr 1995, 125:1690S-1694S.
117. Lehman B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol 2005, 81:1246-1251.
118. Valdivielso J.M., Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006, 371:1-12.
119. Kurabayashi T., Tomita M., Matsushita H., et al. AssociationVitamin D and estrogen receptor gene polymorphism with effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 1999, 180:1115-1120.
120. Hartwell D., Rødbro P., Jensen S.B., Thomsen K., Christiansen C. Vitamin D metabolites-relation to age, menopause and endometriosis. Scand J Clin Lab Invest 1990, 50:115-121.
121. Viganò P., Lattuada D., Mangioni S., Ermellino L., Vignali M., Caporizzo E., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006, 36:415-424.
122. Somigliana E., Panina-Bordignon P., Murone S., Di Lucia P., Vercellini P., Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod 2007, 22:2273-2278.
123. Faserl K., Golderer G., Kremser L., Lindner H., Sarg B., Wildt L., et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2011, 96:E233-E241.
124. Hever A., Roth R.B., Hevezi P., Marin M.E., Acosta J.A., Acosta H., et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A 2007, 104:12451-12456.
125. de Graaff A.A., Dunselman G.A., Delvoux B., van Kaam K.J., Smits L.J., Romano A. B lymphocyte stimulator -817C>T promoter polymorphism and the predisposition for the development of deep infiltrating endometriosis. Fertil Steril 2010, 94:1108-1110.
126. Christofolini D.M., Cavalheiro C.M., Teles J.S., Lerner T.G., Brandes A., Bianco B., et al. Promoter -817C > T variant of B lymphocyte stimulator gene -BLyS, and susceptibility to endometriosis-related infertility and idiopathic infertility in Brazilian population. Scand J Immunol 2011, [Epub ahead of print].
127. Kyogoku C., Morinobu A., Nishimura K., Sugiyama D., Hashimoto H., Tokano Y., et al. Lack of association between tyrosine kinase 2 (TYK2) gene polymorphisms and susceptibility to SLE in a Japanese population. Mod Rheumatol 2009, 19:401-406.
128. Nakamura R., Shibata K., Yamada H., Shimoda K., Nakayama K., Yoshikai Y. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by γδ T cells. J Immunol 2008, 181:2071-2075.
129. Sigurdsson S., Nordmark G., Göring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76:528-537.
130. Sigurdsson S., Padyukov L., Kurreeman F.A., Liljedahl U., Wiman A.C., Alfredsson L., et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007, 56:2202-2210.
131. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009, 41:824-828. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene).
132. Hellquist A., Järvinen T.M., Koskenmies S., Zucchelli M., Orsmark-Pietras C., Berglind L., et al. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. J Rheumatol 2009, 36:1631-1638.
133. Suarez-Gestal M., Calaza M., Dieguez-Gonzalez R., Perez-Pampin E., Pablos J.L., Navarro F., et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus rythematosus genetic factors. Arthritis Rheum 2009, 60:2558-2564.
134. Couturier N., Bucciarelli F., Nurtdinov R.N., Debouverie M., Lebrun-Frenay C., Defer G., et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011, 134:693-703.
135. Tao J.H., Zou Y.F., Feng X.L., Li J., Wang F., Pan F.M., et al. Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases. Mol Biol Rep 2011, 38:4663-4672.